WeVote

Bill

Bill

HB 3530

HEALTH-TECH

104th Regular Session Introduced by Kam Buckner

HB 3530 fixes the short-title wording in Sec. 1 of the Illinois Food, Drug and Cosmetic Act; a purely drafting correction with no policy changes.

Referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 3530

HB 3530 HEALTH-TECH — Summary

Overview
- Bill number and title: HB 3530, HEALTH-TECH
- Purpose: A technical amendment to the Illinois Food, Drug and Cosmetic Act, focused on correcting the wording in the short title section (Sec. 1). The introduced text indicates a drafting fix to the short title language.
- Primary sponsor: Rep. Kam Buckner
- Chamber/assembly: Illinois General Assembly, 104th General Assembly (2025-2026)
- Status: Referred to Rules Committee (as of introduction); subsequently referred to Culture, Recreation & Tourism. The latest status in the record shows Rules Committee referral with subsequent committee referrals.
- Introduced: February 18, 2025 (also listed as filed February 7, 2025; introduced text shows February 18)

What the bill would do (key provisions)
- Amends: Illinois Food, Drug and Cosmetic Act (410 ILCS 620/1)
- Section affected: Section 1 (short title language)
- Text currently in the introduced version (as drafted): “Sec. 1. This Act shall be known and and may be cited as the Illinois Food, Drug and Cosmetic Act.”
- Change intended: A technical correction to the short title language in Sec. 1. The precise corrected phrasing is not explicitly stated in the introduced version, but the bill aims to fix a drafting issue (not a substantive change to the Act’s protections, scope, or regulatory requirements).
- Substantive impact: None anticipated. The amendment is purely textual and administrative, aimed at clarifying or correcting the statute’s short-title reference.

Who is affected
- All entities and individuals subject to the Illinois Food, Drug and Cosmetic Act (manufacturers, distributors, retailers, healthcare providers, and other regulated parties) would be affected only to the extent that the short-title language affects statutory citation and reference. There are no new regulatory requirements or programmatic changes introduced by this bill.

Procedural and timeline aspects
- Filed: February 7, 2025
- Introduced: February 18, 2025
- First reading: February 18, 2025
- Referred to: Rules Committee (initial referral), with subsequent referral to Culture, Recreation & Tourism (March 24, 2025)
- Current status (as listed): Referred to Rules Committee, with actions continuing in committee stages

Notes
- The bill’s title, HEALTH-TECH, suggests a health-tech framing, but the introduced text describes only a technical amendment to the short-title language of the Illinois Food, Drug and Cosmetic Act.
- No fiscal impact or broad policy changes are indicated; the measure appears to be a drafting clean-up rather than a policy expansion or restriction.

In brief, HB 3530 is a technical bill aimed at correcting the short-title language of the Illinois Food, Drug and Cosmetic Act in Sec. 1, with no expected substantive regulatory changes.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.